Proteostasis Therapeutics stock skyrockets on positive trial results
Clinical stage biopharma company Proteostasis Therapeutics (PTI) announced positive preliminary results from a Phase 1 study for the treatment of cystic fibrosis (CF) patients. Shares of Proteostasis jumped more than … Continue reading Proteostasis Therapeutics stock skyrockets on positive trial results
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed